Talphera (TLPH) Return on Capital Employed (2011 - 2026)
Talphera (TLPH) recorded quarterly Return on Capital Employed of 53.95% in Q1 2026, up 15.45% quarter-over-quarter from 63.81% in Q3 2025, and up 4130.0% on a YoY basis from 1.28% in Q1 2025.
Talphera (TLPH) Return on Capital Employed (2011 - 2026) Analysis & Trends
Talphera's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 53.95% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 4130.0% year-over-year to 53.95%; the TTM figure through Mar 2026 stood at 53.95% (up 4130.0% YoY), while the FY2024 annual figure was 91.5%, down 3411.0% from the prior year.
- Return on Capital Employed was 53.95% for Q1 2026 at Talphera, up from 63.81% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 99.53% in Q3 2023 to a low of 101.74% in Q2 2025.
- Historically, Return on Capital Employed has averaged 30.27% across 5 years, with a median of 58.88% in 2025.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed soared 9678 bps in 2023, then sank 18151 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 29.39% in 2022, then plunged by 432 bps to 97.53% in 2023, then increased by 8 bps to 89.83% in 2024, then grew by 29 bps to 63.81% in 2025, then advanced by 15 bps to 53.95% in 2026.
- The last three Return on Capital Employed figures came in at 53.95% (Q1 2026), 63.81% (Q3 2025), and 101.74% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | -53.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.95% |
| Sep 30, 2025 | -63.81% |
| Jun 30, 2025 | -101.74% |
| Mar 31, 2025 | -95.24% |
| Dec 31, 2024 | -89.83% |
| Sep 30, 2024 | -81.99% |
| Jun 30, 2024 | -68.39% |
| Mar 31, 2024 | -74.38% |
| Dec 31, 2023 | -97.53% |
| Sep 30, 2023 | 99.53% |
| Jun 30, 2023 | 87.84% |
| Mar 31, 2023 | 35.14% |
| Dec 31, 2022 | 29.39% |
| Sep 30, 2022 | 2.75% |
| Jun 30, 2022 | -6.69% |
| Mar 31, 2022 | -5.46% |
| Dec 31, 2021 | -13.03% |
| Sep 30, 2021 | -7.74% |
| Jun 30, 2021 | -7.27% |
| Mar 31, 2021 | -2.90% |